What long-term monitoring is needed for patients with hepatitis B (HBV) (Hep B) and cirrhosis?

Updated: Jun 08, 2021
  • Author: Nikolaos T Pyrsopoulos, MD, PhD, MBA, FACP, AGAF; Chief Editor: BS Anand, MD  more...
  • Print

Patients with cirrhosis must be monitored for hepatocellular carcinoma (HCC) by having their AFP levels checked every 6-12 months and undergoing surveillance with abdominal ultrasonography. [106]  Note, however, that AFP levels have been eliminated from the American Association for the Study of Liver Diseases (AASLD) guidelines. [38, 56]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!